Molecular Neurobiology

Special Issues

Following special issues within this section are currently open for submissions:

• Current Developments in Glioblastoma Research and Therapy: 2nd Edition (Deadline: 31 July 2025)
• Neurodegenerative Diseases: From Molecular Mechanisms to Pathophysiology (Second Edition) (Deadline: 31 July 2025)
• Molecular, Cellular and Systems Research on Neuroanatomy, Brain Function and Its Impact on Human Behavior (Deadline: 31 July 2025)
• Cell Death, Inflammation and Oxidative Stress in Neurodegenerative Diseases: 4th Edition (Deadline: 31 July 2025)
• The Neurotoxicity of Amyloid β-Protein (Deadline: 31 July 2025)
• Genomics and Epigenomics in Molecular Neurobiology (Deadline: 31 July 2025)
• Molecular Study and Treatment of Motor Neuron Diseases (Deadline: 20 August 2025)
• Editorial Board Members’ Collection Series: “Molecular Research in NeuroInflammation” (Deadline: 20 August 2025)
• Molecular Mechanisms and Treatments in Neurodegenerative Diseases (Deadline: 20 August 2025)
• Molecular Mechanisms of Neurodegeneration and Neuroprotection for Retinal and Optic Nerve Diseases (Deadline: 20 August 2025)
• Neurodegenerative Diseases: New Insights into Mechanisms, Prevention, Markers, and Therapeutic Targets (Deadline: 20 August 2025)
• Biological Research of Rhythms in the Nervous System (Deadline: 20 August 2025)
• Advances in Neurodegenerative Diseases Research and Therapy—Third Edition (Deadline: 20 August 2025)
• Exploring Mitochondria in Neurodegenerative Disorders: Unveiling Mechanisms and Therapeutic Strategies (Deadline: 20 August 2025)
• Neurodegenerative Disease: From Molecular Basis to Therapy, 3rd Edition (Deadline: 20 August 2025)
• Molecular Mechanisms and Regulation in Blood-Brain Barrier (Deadline: 20 August 2025)
• New Advances in Neuroscience: Molecular Biological Insights (Deadline: 20 August 2025)
• Insights into Neurological and Psychiatric Diseases from Invertebrate Models (Deadline: 20 August 2025)
• Breakthroughs in Diagnostic Prediction and Fundamental Therapeutics of Dementia and Movement Disorders, 2nd Edition (Deadline: 20 August 2025)
• Signaling Pathways in Neuroinflammation or Neurodegenerative Disorders (Deadline: 20 August 2025)
• New Mechanisms and Therapeutics in Neurological Diseases—4th Edition (Deadline: 20 August 2025)
• Neuromodulatory Effects of Serotonin, 2nd Edition (Deadline: 25 August 2025)
• Activation of the Blood–Brain Barrier and Neurological Dysfunction: 2nd Edition (Deadline: 30 August 2025)
• Molecular Mechanism of Sympathetic Nerves in Cardiovascular Diseases and Cancer (Deadline: 30 August 2025)
• State-of-the-Art Molecular Neurobiology in Chile, 2nd Edition (Deadline: 31 August 2025)
• Molecular Mechanisms of Alzheimer’s Disease (Deadline: 31 August 2025)
• Neurotoxicity: Cellular Death Mechanisms in the Pathogenesis of Neurodegenerative Diseases (Deadline: 31 August 2025)
• Molecular Insights into Anxiety and Depression: Pathomechanisms and Therapeutic Strategies (Deadline: 31 August 2025)
• Neurodegenerative Disorders: Advances in Mechanisms, Models, and Therapeutics (Deadline: 31 August 2025)
• Advances in Amyloid Aggregation and Its Inhibition: Implementing Insights from Physiological Conditions (Deadline: 31 August 2025)
• Recent Molecular Research in Neuroimmunology (Deadline: 31 August 2025)
• Molecular and Cellular Neurobiology of Headache and Migraine (Deadline: 31 August 2025)
• New Insights in Prion Diseases (Deadline: 20 September 2025)
• New Advances in Glioma Knowledge: From Genome to Signal Pathways Alterations (Deadline: 20 September 2025)
• Tau Pathobiology in Neurodegenerative Diseases: From Molecular Mechanisms to Therapeutic Advances (Deadline: 20 September 2025)
• New Trends in Research on Cerebral Ischemia (Deadline: 20 September 2025)
• From Molecular Insights to Novel Therapies: Neurological Diseases (Deadline: 20 September 2025)
• Demyelinating Diseases: From Molecular Mechanisms to, Therapeutic Strategies—3rd Edition (Deadline: 20 September 2025)
• Drug-Induced Neurotoxicity and Neurodegeneration: Mechanisms, Models and Implications (Deadline: 20 September 2025)
• Glutamatergic Signaling in the Nervous System (Deadline: 20 September 2025)
• The Role of Choroid Plexus in Neurological Health (Deadline: 20 September 2025)
• Bioactive Compounds in Human Brain Structures and Diseases: 2nd Edition (Deadline: 20 September 2025)
• The Impact and Alterations of Hormones in Age-Related Diseases and Comorbidities (Deadline: 20 September 2025)
• Molecular Research in Spinal Cord Injury (Deadline: 20 September 2025)
• The Blood–Brain Barrier and Neuroprotection (Deadline: 20 September 2025)
• Physiological Functions and Pathological Effects of Microglia (Deadline: 20 September 2025)
• Molecular Insights into Role of Anthranilic Acid in Neuropsychiatric Diseases (Deadline: 20 September 2025)
• Recent Advances in Retinal Neurobiology (Deadline: 20 September 2025)
• The Role of the Endocannabinoid System in Reward- and Addiction-Related Neuroplasticity (Deadline: 20 September 2025)
• Neurodegenerative Diseases: Molecular Mechanisms and Therapies, 3rd Edition (Deadline: 20 September 2025)
• Molecular Advances in Research of Neuroendocrine Tumors (Deadline: 20 September 2025)
• Molecular Mechanisms and Drug Treatment in Alzheimer’s Disease (Deadline: 20 September 2025)
• Amyotrophic Lateral Sclerosis Behind Motor Neurons (Deadline: 20 September 2025)
• A New Era for Structures and Functions of Amyloid Fibrils in Neurodegenerative Diseases (Deadline: 20 September 2025)
• The Gut-Brain Axis: Genomic and Metagenomic Involvement (Deadline: 20 September 2025)
• CNS Injuries: 2nd Edition (Deadline: 20 September 2025)
• New Research Progresses on Multifaceted Cholinergic Signaling (Deadline: 20 September 2025)
• The Function of Glial Cells in the Nervous System: 2nd Edition (Deadline: 20 September 2025)
• Mechanism of Cellular Signaling, Dysfunction, and Drug Effects on Alzheimer's Disease (Deadline: 20 September 2025)
• Peripheral Neuropathies: Molecular Research and Novel Therapy—2nd Edition (Deadline: 20 September 2025)
• Role of Glia in Human Health and Disease (Deadline: 20 September 2025)
• Mechanosensitive Ion Channels in the Nervous System (Deadline: 20 September 2025)
• Unveiling Molecular Mysteries of Brain Barriers (Deadline: 25 September 2025)
• Molecular Insights in Neurodegeneration (Deadline: 25 September 2025)
• Latest Advances in Oxidative Stress and Brain Injury (Deadline: 28 September 2025)
• Novel Concepts, New Perspectives, and Current Therapies for Parkinson’s Disease: 2nd Edition (Deadline: 30 September 2025)
• Neurogenesis and Neurodegeneration: Insights into Regeneration and the Impact of Neurotrophins (Deadline: 30 September 2025)
• Molecular Mechanism and Pharmacological Target of Neuroprotection (Deadline: 30 September 2025)
• Advances in Epigenetics of Mental Disorders (Deadline: 30 September 2025)
• Natural Products for Neuroprotection and Neurodegeneration (Deadline: 30 September 2025)
• Statin Induced Neurotoxicity (Deadline: 30 September 2025)
• Alzheimer’s Disease: Molecular Mechanisms and Novel Therapies (Deadline: 30 September 2025)
• Molecular Mechanisms of Mitochondrial Neurodegenerative Diseases (Deadline: 30 September 2025)
• Molecular Research on Stroke (Deadline: 30 September 2025)
• Advances in Aging and Alzheimer’s Disease Research: From Molecular Mechanisms to Therapeutics—2nd Edition (Deadline: 30 September 2025)
• Drug Development and Discovery for Alzheimer's Disease (Deadline: 30 September 2025)
• Neural Crest Development in Health and Disease (Volume 2) (Deadline: 20 October 2025)
• Novel Therapeutic Strategies for Neurodegenerative Disease (Deadline: 20 October 2025)
• Novel Extracellular Vesicle-Based Therapy for Central Nervous System Diseases (Deadline: 20 October 2025)
• Brain Plasticity in Health and Disease (Deadline: 20 October 2025)
• DNA Damage in Neurological Disorders: Etiological and Therapeutical Aspects (Deadline: 20 October 2025)
• Neurodegenerative Disease: Looking for Oxidative Stress and Inflammation Mechanisms (Deadline: 20 October 2025)
• Role of Cortex in Health and Disease (Deadline: 20 October 2025)
• Predictive and Diagnostic Biomarkers in Inflammatory and Neurodegenerative Diseases (Deadline: 20 October 2025)
• Cell Pathways Underlying Neuronal Differentiation (Deadline: 20 October 2025)
• Molecular and Cellular Mechanisms in Mood Disorders (Deadline: 20 October 2025)
• Novel Insights into Microglia Heterogeneity and Neurodegeneration (Deadline: 20 October 2025)
• Spinocerebellar Ataxias: Uncovering Their Molecular Mechanisms, Biomarker Development, and Therapies (Deadline: 20 October 2025)
• Molecular Mechanisms of Drug Discovery, Treatment, and Repurposing in Neuropsychiatric Disorders (Deadline: 20 October 2025)
• Molecular Studies of Mutations Related to Neurodegenerative Diseases (Deadline: 20 October 2025)
• Multi-Omics Approaches to Disentangle Pathomechanisms in Neurological Disease (Deadline: 20 October 2025)
• Application of Biomarkers in Spinal Muscular Atrophy (SMA) (Deadline: 20 October 2025)
• Pathophysiology and Pharmacology in Psychiatry (Deadline: 20 October 2025)
• Neuronal Differentiation: From Pathology to Therapeutic Strategies (Deadline: 20 October 2025)
• Molecular Insights into Addiction (Deadline: 20 October 2025)
• Depression: From Molecular Basis to Therapy—2nd Edition (Deadline: 20 October 2025)
• Challenges of Acute Ischemic Stroke (Deadline: 20 October 2025)
• Molecular Signatures in Autism Spectrum Disorders (Deadline: 20 October 2025)
• Progress in Astrocyte Research (Deadline: 20 October 2025)
• Molecular Research in Epilepsy (Deadline: 20 October 2025)
• Pathogenic Proteins in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Innovations (Deadline: 20 October 2025)
• Amyotrophic Lateral Sclerosis (ALS): Pathogenesis and Treatments (Deadline: 20 October 2025)
• Neurological Diseases: From Physiology to Therapy (Deadline: 20 October 2025)
• Molecular Advances in Neuroimaging (Deadline: 22 October 2025)
• Recent Molecular Basis of Neurocognitive Mechanism (Deadline: 25 October 2025)
• Gut–Brain Axis: Pathophysiological Mechanisms in Neurological Disorders and Metabolic Diseases (Deadline: 25 October 2025)
• New Advances in Research on Alzheimer’s Disease: 2nd Edition (Deadline: 30 October 2025)
• Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies (Deadline: 30 October 2025)
• Advancement of Understanding Alzheimer’s Disease Susceptibility and Novel Drug Targets (Deadline: 30 October 2025)
• Dysfunctional Neural Circuits and Impairments in Brain Function, 2nd Edition (Deadline: 30 October 2025)
• Neurodegenerative Disease: Genetic Bases and Pathogenetic Mechanism (Deadline: 30 October 2025)
• Emerging Biological and Molecular Targets in Schizophrenia (Deadline: 30 October 2025)
• Recent Advances in Neurofibromatosis Type 1: From Molecular Insights to Novel Therapies (Deadline: 30 October 2025)
• Effects of Chemicals on Brain Health and Development (Deadline: 30 October 2025)
• Latest Review Papers in Molecular Neurobiology 2025 (Deadline: 31 October 2025)
• Emerging Treatments in Aging-Related Cerebrovascular Diseases (Deadline: 31 October 2025)
• Advanced Molecular Diagnostic Approaches for Neurodevelopmental Disorders: Applications and Future Perspectives (Deadline: 31 October 2025)
• Molecular Research in Brain Cancer (Deadline: 31 October 2025)
• New Insights and Discoveries in the Pathogenesis, Diagnosis and Therapy of Neuromuscular Diseases (Deadline: 31 October 2025)
• Molecular Genetics in the Pathogenesis of Neurological Disorders (Deadline: 31 October 2025)
• Perineuronal Nets and Fear Memories Erasure: State of the Art and Future Directions (Deadline: 31 October 2025)
• Blood–Brain Barrier Dysfunction in Neurodegenerative Disorders (Deadline: 31 October 2025)
• Molecular Targets of Disease—Changing Treatment Strategies for Parkinson's Disease (Deadline: 31 October 2025)
• Unraveling the Molecular Landscape of Primary Brain Tumors (Deadline: 31 October 2025)
• Translational Neuroscience of Emotion, Cognition, and Behavior: From Mechanisms to Mental Health (Deadline: 31 October 2025)
• Neuropeptides in Brain Health and Disease: From Molecular Mechanisms to Therapeutic Potential (Deadline: 31 October 2025)
• Abnormal Organelles and Protein Expression in Acute and Chronic Neurodegeneration (Deadline: 20 November 2025)
• Involvement of Neuroinflammatory Processes in Psychiatric Conditions (Deadline: 20 November 2025)
• Basic, Translational and Clinical Research on Dementia—Second Edition (Deadline: 20 November 2025)
• Advancements in Alzheimer’s Disease Treatment: Exploring Novel Approaches and Strategies (Deadline: 20 November 2025)
• Synapse Dynamics: From Molecular Mechanisms to Functional Plasticity (Deadline: 20 November 2025)
• Nucleolus, Nucleolar Stress, and Ribosome Biogenesis in the Nervous System (Deadline: 20 November 2025)
• Computational Modelling at the Blood–Brain Barrier (Deadline: 20 November 2025)
• Pain: From Molecular Basis to Therapy (Deadline: 20 November 2025)
• Neuroinflammation: From Molecular Mechanisms to Therapy (Deadline: 20 November 2025)
• Anti-Inflammatory Strategies and Cell Models for Alzheimer’s Disease (Deadline: 20 November 2025)
• New Therapeutic Targets for Neuroinflammation and Neurodegeneration (Deadline: 20 November 2025)
• Glial Cells in Neurodegenerative Disorders (Deadline: 20 November 2025)
• Molecular Advances in the Neurological Underpinnings of Consciousness (Deadline: 20 November 2025)
• Molecular Mechanisms and Emerging Therapies in Neurovascular Disease (Deadline: 20 November 2025)
• The Role of Amyloid in Neurological Diseases (Deadline: 20 November 2025)
• Mechanisms and Implications of Traumatic Brain Injury and Neuroinflammation (Deadline: 20 November 2025)
• Molecular Diagnostics in Neurological Diseases (Deadline: 20 November 2025)
• Signaling Molecules in Neurological Health and Disease (Deadline: 25 November 2025)
• Melatonin: Physiological Effects on Health and Diseases (Deadline: 30 November 2025)
• Cellular and Molecular Mechanisms of Blood–Brain Barrier (BBB) Dysfunction and Dementia (Deadline: 30 November 2025)
• Zebrafish Model for Neurological Research (Deadline: 30 November 2025)
• Molecular Mechanisms of Neurological and Psychiatric Disease, 2nd Edition (Deadline: 30 November 2025)
• Molecular Advances in Biomarkers of Central Nervous System Diseases and Disorders (Deadline: 30 November 2025)
• Neuroinflammation: Emerging Insights and Advances in Drug Development (Deadline: 30 November 2025)
• Wired for Change: Neurotransmitter Plasticity and Circuit Dynamics in Health and Disease (Deadline: 30 November 2025)
• Microglia in Neurological Disorders: Potential Therapeutic Targets and Underlying Mechanisms (Deadline: 30 November 2025)
• AI and Machine Learning in Molecular Biomarker Discovery and Mechanisms of Neurodegenerative Disorders (Deadline: 30 November 2025)
• Latest Research in Neuroinflammation (Deadline: 30 November 2025)
• Neurobiology and Psychopharmacology of Mood Disorders (Deadline: 30 November 2025)
• Brain Stroke Across the Lifespan: Mechanisms, Models, Translational Advances and Impacts Beyond the Brain (Deadline: 30 November 2025)
• The Current Landscape of Microglia-Glioma Research: From Basic Science to Therapeutic Potential (Deadline: 1 December 2025)
• Pharmacological Treatment of Neuroinflammation (Deadline: 20 December 2025)
• Genetic Research in Neurological Diseases (Deadline: 20 December 2025)
• Molecular Insights into Multiple Sclerosis (Deadline: 20 December 2025)
• Advances in Synaptic Transmission and Plasticity (Deadline: 20 December 2025)
• Molecular Mechanisms of Age-Related Cognitive Decline (Deadline: 20 December 2025)
• Molecular Basis of Neuropsychiatric Disorders: Recent and Future Developments (Deadline: 20 December 2025)
• The Role of Neurons in Human Health and Disease—3rd Edition (Deadline: 20 December 2025)
• Molecular Mechanisms and Signaling Pathways in Alzheimer’s Disease (Deadline: 20 December 2025)
• Understanding and Treating Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases (Deadline: 20 December 2025)
• Physiology and Pathophysiology of Neurodegeneration: New Insights and Advances from Molecular to Cellular Level (Deadline: 20 December 2025)
• Neuroimaging Studies in Exploring the Molecular Mechanisms of Neurological Diseases (Deadline: 20 December 2025)
• Development of Dopaminergic Neurons, 4th Edition (Deadline: 20 December 2025)
• Neuroinflammation: Advancements in Pathophysiology and Therapies (2nd Edition) (Deadline: 20 December 2025)
• Molecular Research on Depression—2nd Edition (Deadline: 20 December 2025)
• Future Perspectives and Challenges in Molecular Research of Glioma (Deadline: 20 December 2025)
• Advancing Mental Disorder Therapies: Drug Repositioning and Translational Insights from Animal Models (Deadline: 20 December 2025)
• Neurobiological Mechanisms of Addictive Disorders (Deadline: 30 December 2025)
• Traumatic Brain Injury/Chronic Traumatic Encephalopathy as Cause of Alzheimer’s Disease: Physics and Molecular Biology in the Genesis of Neurodegeneration? (Deadline: 30 December 2025)
• Neurogenetic Disorders: Neurogenetics, Pathogenesis, and Gene Therapy (Deadline: 30 December 2025)
• Molecular Investigations in Neurodevelopmental Disorders (Deadline: 30 December 2025)
• Molecular and Cellular Mechanisms in Learning and Memory (Deadline: 30 December 2025)
• Potential Prevention and Treatment of Neurodegenerative Disorders (Deadline: 30 December 2025)
• Vascular, Oxidative and Inflammatory Dysregulation in Neurodegenerative Diseases: Current Status and Future Therapeutic Perspectives: 2nd Edition (Deadline: 30 December 2025)
• Challenges and Innovation in Neurodegenerative Diseases, 2nd Edition (Deadline: 30 December 2025)
• Molecular Research on Pathophysiology of Multiple Sclerosis and Neuroinflammation (Deadline: 30 December 2025)
• Neuroimmune Regulation of Acute and Chronic Pain (Deadline: 30 December 2025)
• Animal Research Model for Neurological Diseases, 2nd Edition (Deadline: 30 December 2025)
• Advances in the Genetic Research on Psychiatric Disorders (Deadline: 30 December 2025)
• Role of Mitochondria in Neurodegenerative Diseases (Deadline: 30 December 2025)
• New Challenges of Parkinson’s Disease, 2nd Edition (Deadline: 30 December 2025)
• Molecular Aspects of Retinal Neurodegeneration and Neuroprotection (Deadline: 30 December 2025)
• 25th Anniversary of IJMS: Updates and Advances in Molecular Neurobiology (Deadline: 31 December 2025)
• Molecular Perspective of Alzheimer’s Disease (Deadline: 31 December 2025)
• Molecular Mechanisms and Therapeutic Targets in Brain Tumor Pathogenesis (Deadline: 31 December 2025)
• Molecular Crosstalk in Stress-Induced Psychopathology (Deadline: 31 December 2025)
• Gene Regulation and Neurotoxicity in Alcohol Related Pathologies (Deadline: 31 December 2025)
• Detrimental and Beneficial Roles of Glial Cells After Neural Disorders (Deadline: 31 December 2025)
• Molecular Mechanisms and Pathophysiology of Peripheral Neuropathies and Neuromuscular Disorders (Deadline: 31 December 2025)
• Recent Advances in Metabolism of Alzheimer’s Disease (Deadline: 31 December 2025)
• New Trends in Alzheimer’s Disease Research: From Molecular Mechanisms to Therapeutics: 3rd Edition (Deadline: 31 December 2025)
• Molecular Signatures in Overt Neurodegenerative Disease: Toward Precision Diagnosis and Classification (Deadline: 1 January 2026)
• Advances in Research on Neurotransmitters (Deadline: 20 January 2026)
• Drug Delivery to the Central Nervous System: From Design, Synthesis, and Evaluation (Deadline: 20 January 2026)
• Neurological Diseases: From Molecular Basis to Therapy (Deadline: 20 January 2026)
• Focus on Hippocampus Biology: From Neurophysiology to Dysfunctions (2nd Edition) (Deadline: 20 January 2026)
• Molecular Mechanisms Underlying Vulnerability to Stress-Related Disorders (Deadline: 20 January 2026)
• New Advances in the Treatment and Diagnosis of Neuromuscular Diseases (Deadline: 20 January 2026)
• Molecular Research in Parkinson's Disease (Deadline: 20 January 2026)
• Neurodegeneration and Neuroinflammatory Processes in Age-Related Diseases (Deadline: 20 January 2026)
• Neurological Disorders: From Molecular Mechanisms to Nanomedicine (Deadline: 20 January 2026)
• Advances in the Physiopathology of Neurodevelopmental Disorders (Deadline: 20 January 2026)
• The Latest Molecular and Psycho-Physiological Insights on “Brain Fatigue” (Deadline: 20 January 2026)
• New Insights into Chronic Inflammatory Demyelinating Polyneuropathy and Neuroimmunological Diseases (Deadline: 20 January 2026)
• Multiple Sclerosis: From Molecular Pathology to Novel Therapeutic Approaches (Deadline: 20 January 2026)
• Neuroinflammation and Cellular Senescence in Brain Aging and Neurodegeneration: From Molecular Mechanisms to Therapeutic Applications (Deadline: 20 January 2026)
• The Brain’s Regeneration Potential: The Role of Neural Progenitor Cells in Neuropsychiatric Therapy (Deadline: 20 January 2026)
• Natural Compounds in Neurological Diseases (Deadline: 20 January 2026)
• Molecular Research in Epilepsy and Epileptogenesis—2nd Edition (Deadline: 20 January 2026)
• Advances in the Molecular Diagnosis and Treatment of Neurodegenerative Diseases (Deadline: 20 January 2026)
• Molecular Insights into Microglia in Neurological Diseases (Deadline: 20 January 2026)
• Molecular Insights and Therapeutic Advances in Cerebral and Spinal Tumors (Deadline: 31 January 2026)
• New Insights into the Mechanisms of Neurodegeneration and Regeneration: From Bench to Bedside (Deadline: 31 January 2026)
• Molecular and Cellular Mechanism in Neuroinflammation Research (Deadline: 31 January 2026)
• Stress-Related Disorders and Depression: From Molecular Basis to Therapy (3rd Edition) (Deadline: 31 January 2026)
• Neuropharmacological Innovations in Treating Neurodegenerative Diseases (Deadline: 31 January 2026)
• Unraveling Affective Disorders: From Pathogenesis to Drug Therapy (Deadline: 31 January 2026)
• Novel Mechanisms for the Prevention and Treatment of Stroke (Deadline: 10 February 2026)
• Monoamine Signalling Pathways as a Target for Pathomechanism of Mental Disorders and Pharmacotherapy (Deadline: 20 February 2026)
• Molecular Research and Insight in Neurotransmission and Neuromodulation (Deadline: 20 February 2026)
• Progression of Multiple Sclerosis: Environmental Factors, Genetics, Therapeutics and Immunopathogenesis (Deadline: 20 February 2026)
• Molecular Mechanisms and Neural Circuits in Behavioral Neuroscience (Deadline: 20 February 2026)
• Exploring Biological Mechanisms and Therapeutic Strategies for Substance Use Disorders (Deadline: 20 March 2026)
• Unraveling the Molecular Mechanisms of Neurodegeneration (Deadline: 20 March 2026)
• Genetic Diversity, Founder Effects, and Migration in Neurodegeneration: Molecular and Population Perspectives (Deadline: 20 March 2026)
• Metabolic–Epigenetic Interplay in Healthy and Diseases (Deadline: 31 March 2026)
• Molecular Insights and Therapeutic Innovations in Neuromuscular Diseases (Deadline: 30 April 2026)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Feature Papers in Molecular Neurobiology
• Molecular Research on Neuroimmunology (Closed)
• Novel Insights into the Sleeping, Waking, and Dreaming Brain
• State-of-the-Art Molecular Neurobiology in Germany (Closed)
• State-of-the-Art Molecular Neurobiology in Russia (Closed)